A phase 2 study of ridaforolimus and dalotuzumab in estrogen receptor positive breast cancerJosé Baselga, Hope S. Rugo, Ahmad Awada et al.|University of Southern Denmark Research Portal (University of Southern Denmark)|2013Cited by 0